Natural crude drugs to permit clinical study after commercial release

Published: 2002-05-15 07:00:00

Updated: 2002-05-15 07:00:00

To boost a new natural crude drug development, the KFDA is now preparing a draft reflecting the promotional policy and going to announce it in public around the coming May, which contains special privileges with permission for the clinical studies after its commercial release and exemption of saf...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK